← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2001Last known activity
Jul 1, 2008
Defunct as of Jul 1, 2018
Timeline
1990s
- Jun 1, 1999
Anesiva, Inc.— Founded
2000s
- Sep 26, 2005
AlgoRx Pharmaceuticals— Acquired
- Aug 5, 2009
Arcion Therapeutics Inc— Acquired
2010s
- Jul 1, 2018
Anesiva, Inc.— Defunct
Drugs by trial phase (6 distinct, 18 trials)
Phase 3 (2 own, 2 via acquisition)
Phase 2 (1 own, 1 via acquisition)
Indications
Studied for
- Arterial Occlusive Diseases
- Coronary Artery Disease
- Coronary Disease
- Dermatitis
- Dermatitis, Atopic
- Eczema
- Graft Occlusion, Vascular
- Hallux Valgus
- Hyperplasia
- Ischemia
- Kidney Failure, Chronic
- Myocardial Ischemia
- Osteoarthritis
- Osteoarthritis, Knee
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Vascular Diseases
Subsidiaries (2 direct, 2 total across the full acquisition tree)
Recent trials (15)
- NCT00672568Study directorPhase 2Jul 1, 2008
- NCT00672568Lead sponsorPhase 2Jul 1, 2008
- NCT00656578Lead sponsorPhase 3Mar 1, 2008
- NCT00681356Study directorPhase 3Sep 1, 2007
- NCT00683267Lead sponsorPhase 2Sep 1, 2007
- NCT00681356Lead sponsorPhase 3Sep 1, 2007
- NCT00683267Study directorPhase 2Sep 1, 2007
- NCT00667654Study directorPhase 2Aug 1, 2007
- NCT00125333Study directorPhase 1/Phase 2Mar 1, 2005
- NCT00125333Lead sponsorPhase 1/Phase 2Mar 1, 2005
- NCT00086164Lead sponsorPhase 1/Phase 2May 1, 2004
- NCT00042081Lead sponsorPhase 3Jul 1, 2002
- NCT00042081Study directorPhase 3Jul 1, 2002
- NCT00041925Lead sponsorPhase 2/Phase 3Nov 1, 2001
- NCT00041925Study directorPhase 2/Phase 3Nov 1, 2001
Details
- Founded
- South San Francisco, CA, US Jun 1, 1999
- Last known activity
- Jul 1, 2008